Zhang Y - Search Results

1

MG53 protects against contrast-induced acute kidney injury by reducing cell membrane damage and apoptosis.

Liu C, Hu YH, Han Y, Wang YB, Zhang Y, Zhang XQ, He DF, Ren HM, Liu YK, Wang HY, Tan T, Lin PH, Li HC, Rovin BH, Ma JJ, Zeng CY. Liu C, et al. Among authors: zhang xq, zhang y. Acta Pharmacol Sin. 2020 Nov;41(11):1457-1464. doi: 10.1038/s41401-020-0420-8. Epub 2020 May 18. Acta Pharmacol Sin. 2020. PMID: 32424239 Free PMC article.

2

Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.

Weisleder N, Takizawa N, Lin P, Wang X, Cao C, Zhang Y, Tan T, Ferrante C, Zhu H, Chen PJ, Yan R, Sterling M, Zhao X, Hwang M, Takeshima M, Cai C, Cheng H, Takeshima H, Xiao RP, Ma J. Weisleder N, et al. Among authors: zhang y. Sci Transl Med. 2012 Jun 20;4(139):139ra85. doi: 10.1126/scitranslmed.3003921. Sci Transl Med. 2012. PMID: 22723464 Free PMC article.

3

GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.

Zhang Y, Wang S, Huang H, Zeng A, Han Y, Zeng C, Zheng S, Ren H, Wang Y, Huang Y, Jose PA, Ma XL, Zeng C, Chen K. Zhang Y, et al. Clin Sci (Lond). 2020 Sep 30;134(18):2453-2467. doi: 10.1042/CS20200671. Clin Sci (Lond). 2020. PMID: 32940654 Free PMC article.

4

MG53 participates in ischaemic postconditioning through the RISK signalling pathway.

Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM, Xiao RP. Zhang Y, et al. Cardiovasc Res. 2011 Jul 1;91(1):108-15. doi: 10.1093/cvr/cvr029. Epub 2011 Feb 1. Cardiovasc Res. 2011. PMID: 21285295 Free PMC article.

5

MG53 is a double-edged sword for human diseases.

Zhang Y, Wu HK, Lv FX, Xiao RP. Zhang Y, et al. Sheng Li Xue Bao. 2016 Aug 25;68(4):505-16. Sheng Li Xue Bao. 2016. PMID: 27546510 Free article. Review.

6

MG53: Biological Function and Potential as a Therapeutic Target.

Zhang Y, Wu HK, Lv F, Xiao RP. Zhang Y, et al. Mol Pharmacol. 2017 Sep;92(3):211-218. doi: 10.1124/mol.117.108241. Epub 2017 Apr 21. Mol Pharmacol. 2017. PMID: 28432201 Review.

7

Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.

Wu HK, Zhang Y, Cao CM, Hu X, Fang M, Yao Y, Jin L, Chen G, Jiang P, Zhang S, Song R, Peng W, Liu F, Guo J, Tang L, He Y, Shan D, Huang J, Zhou Z, Wang DW, Lv F, Xiao RP. Wu HK, et al. Among authors: zhang s, zhang y. Circulation. 2019 Feb 12;139(7):901-914. doi: 10.1161/CIRCULATIONAHA.118.037216. Circulation. 2019. PMID: 30586741

8

MG53 constitutes a primary determinant of cardiac ischemic preconditioning.

Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, Lv F, Zhang Y, Song R, Hwang M, Jin L, Guo J, Peng W, Li G, Nishi M, Takeshima H, Ma J, Xiao RP. Cao CM, et al. Among authors: zhang y. Circulation. 2010 Jun 15;121(23):2565-74. doi: 10.1161/CIRCULATIONAHA.110.954628. Epub 2010 Jun 1. Circulation. 2010. PMID: 20516375

9

Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H₂O₂-Activated Protein Kinase C-δ Signaling.

Shan D, Guo S, Wu HK, Lv F, Jin L, Zhang M, Xie P, Wang Y, Song Y, Wu F, Lan F, Hu X, Cao CM, Zhang Y, Xiao RP. Shan D, et al. Among authors: zhang m, zhang y. Circulation. 2020 Sep 15;142(11):1077-1091. doi: 10.1161/CIRCULATIONAHA.119.044998. Epub 2020 Jul 17. Circulation. 2020. PMID: 32677469

10

Knockout of TRPA1 exacerbates angiotensin II-induced kidney injury.

Ma S, Zhang Y, He K, Wang P, Wang DH. Ma S, et al. Among authors: zhang y. Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F623-F631. doi: 10.1152/ajprenal.00069.2019. Epub 2019 Jul 24. Am J Physiol Renal Physiol. 2019. PMID: 31339777 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,871 results

Search Page

Filters